These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 27592131)
1. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment. Yu D; Li W; Zhang Y; Zhang B Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy. Xiao Y; Wang S; Zong Q; Yin Z AAPS PharmSciTech; 2018 Jul; 19(5):2395-2406. PubMed ID: 29869309 [TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
5. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery. Zhang B; Zhang Y; Yu D Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy. Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948 [TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel. Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984 [TBL] [Abstract][Full Text] [Related]
8. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles. Baek JS; Cho CW Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604 [TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Zhang L; Yao J; Zhou J; Wang T; Zhang Q Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024 [TBL] [Abstract][Full Text] [Related]
10. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677 [TBL] [Abstract][Full Text] [Related]
11. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. Zhao F; Yin H; Li J Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
13. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133 [TBL] [Abstract][Full Text] [Related]
14. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
17. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors. Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
19. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093 [TBL] [Abstract][Full Text] [Related]
20. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Wang W; Xi M; Duan X; Wang Y; Kong F Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]